Press Releases

eClinical Solutions Introduces Protocol Deviations Among New Product Innovations Boosting Operational Success for Clinical Trials

eClinical Solutions announced newly released product enhancements and AI-enabled functionality within the elluminate Clinical Data Cloud ®. Recent platform updates offer clinical teams increased oversight and efficiency amid trial complexity and advance the AI technology footprint of life sciences organizations.

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis ("AIM-MASH") on the AISight Image Management System

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, is proud to announce the launch of its AIM-MASH product on the AISightⓇ Image Management System (IMS). This product provides advanced AI-based measurement (AIM) to support the analysis of MASH Clinical Research Network (CRN) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Activity Score (MAS) component grades and fibrosis staging. The launch of AIM-MASH on AISight aims to increase the reproducibility and scalability of pathologists' assessments and management of MASH cases, which are projected to reach 27 million in the US alone by 2030.

Healthcasts Updates Provider Consult and Research Tool

Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics at Baylor College of Medicine have entered a lab agreement focusing on innovation and high-risk projects that have potentially great clinical impact. This latest collaboration allows for the translation of cutting-edge research into clinical diagnostics, benefiting from BCM’s academic and medical expertise and the clinical diagnostic expertise of Baylor Genetics, in anticipation of larger scale launch when commercially feasible

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

Longhorn Vaccines and Diagnostics Provides Mid-Year Progress on Vaccine and Diagnostic Divisions

AVIA’s Generative AI Strategic Collaborative Enters Phase 2, Accelerating Healthcare AI Adoption and Real-World Applications

Clearwater Managed Cloud Services Help Healthcare Organizations Leverage the Power of Microsoft Azure with Reduced Risk

Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation

Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards

Creative BioMart Expands Native Proteins Offering to Advance Scientific Research and Discovery

Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen

Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Clarapath Closes $36M Series B Round to Transform 150-year old Laboratory Processes

Clarapath Closes $36M Series B Round to Transform 150-year old Laboratory Processes

SSI Strategy and Metalmind Partner for Enterprise AI Solutions

SSI Strategy LLC has announced a partnership with MPS Metalmind AB emphasizing its commitment to leveraging cutting-edge artificial intelligence to drive innovation and enhance business capabilities.

Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure

Ceryx Medica has announced the trial approval for Cysoni-XT, a new temporary cardiac pacemaker aiming to boost recovery in heart failure.

Association for Molecular Pathology Publishes Recommendations to Facilitate Design and Implementation of Clinical Pharmacogenomic DPYD Genotyping Assays

The Association for Molecular Pathology today published consensus recommendations to aid in the design and validation of clinical DPYD genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

Clearwater Adds NIST CSF 2.0 and PCI DSS Assessments to IRM|Performance™ Module in IRM|Pro® Software Suite

Huateng Pharma Unveils Y-Shape PEG NHS for Enhanced Drug PEGylation

Huateng Pharma has launched Y-Shape PEG NHS, an advanced PEGylation solution that enhances protein drug development by improving water solubility and biocompatibility through efficient and selective modification of proteins.

Biopharma PEG Announces Key Product Line of Monodispersed PEGs for Advanced Pharmaceutical Applications

Biopharma PEG announces its advanced line of monodispersed PEGs, crucial for ADC and PROTAC linkers, as well as PEGylated proteins and peptides, enhancing pharmaceutical stability and delivery.

‘Biolyst Scientific’ Announced as New Brand Name to Encompass EMS and Azer, Will Deepen Offerings to Clinical and Research Lab Customers

Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific.